Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-04-11

Clinical Trial Update: A Clinical Trial Comparing Oseltamivir With Placebo And Zanamivir With Control As First Line Treatment For Human Swine Influenza Infection [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing oseltamivir with placebo and zanamivir with control for human swine influenza infection was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RELENZA (zanamivir)
  • Tamiflu (oseltamivir)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Upper Respiratory Tract Infection, Influenza | Phase 3 | Status: TERMINATED